510(k) Report

510(k) · Cleared

Cleared

Sepragel Sinus

K012532510(k) TraditionalCleared Oct 30, 200185-day reviewClass I21 CFR 874.4780

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Genzyme Corp. · LYA Splint, Intranasal Septal

Cleared on Oct 30, 2001 as substantially equivalent to K982731 (Xomed, Inc., 1999) and 2 other predicates after an 85-day review. Its family tree reaches back 1 generation to 1997. 47 later devices descend from it.

Decided
Oct 30, 2001
Review
85 days
Class
Class I
Product code
LYA
Recalls
None
Predicates
3

Its longest line of descent runs back 1 generation to K972082 (1997). 3 ancestors in all. 47 later devices descend from it, 6 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2001: 1 other ancestor1999: 1 other ancestor2005: 2 descendants cleared2003: 1 descendant cleared2007: 5 descendants cleared2006: 2 descendants cleared2008: 3 descendants cleared2012: 4 descendants cleared2010: 2 descendants cleared2014: 6 descendants cleared2020: 1 descendant cleared2016: 1 descendant cleared2009: 2 descendants cleared2011: 1 descendant cleared2022: 1 descendant cleared2015: 2 descendants cleared2017: 2 descendants cleared2013: 2 descendants cleared2019: 4 descendants cleared2018: 3 descendants cleared2024: 1 descendant cleared2021: 1 descendant cleared2023: 1 descendant clearedK972082 · Custom Nasal Splint · Boston Medical Products, Inc. · 19971995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors 1 generation forward: 6 descendants2 generations forward: 14 descendants3 generations forward: 15 descendants4 generations forward: 9 descendants5 generations forward: 3 descendants K972082 · Custom Nasal Splint · Boston Medical Products, Inc. · 19970+5
  1. Root · 1 generation backK972082 Custom Nasal SplintBoston Medical Products, Inc. · 1997
  2. This deviceK012532 Sepragel SinusGenzyme Corp. · 2001
  3. Descendant · cites it directly · 29 of its ownK033666 HemadermMedafor, Inc. · 2003
  4. Descendant · 2 generations on · 28 of its ownK070211 Traumarrest and Bleedarrest Hemostatic Particles and FoamHemostasis, LLC · 2007
  5. Descendant · 3 generations on · 19 of its ownK072900 Excelarrest FoamHemostasis, LLC · 2007
  6. Descendant · cites it directly · 17 of its ownK052099 Nasopore Nasal Dressing, Model Ndox-Yyy/ZZPolyganics B.V., · 2005
  7. Descendant · 2 generations on · 11 of its ownK080818 Hemcon Bandage, Hemcon Bandage Otc, Hemcon Chitoflex-Surgical DressingHem Con Medical Technologies, Inc. · 2008

Showing 5 of 47 descendants. See all descendants

Descendants cleared per year

2003: 12005: 22006: 22007: 52008: 32009: 22010: 22011: 12012: 42013: 22014: 62015: 22016: 12017: 22018: 32019: 42020: 12021: 12022: 12023: 12024: 1
2003high 6 (2014) · low 0 (2004)2026

Most influential descendants

Showing 5 of 47 · See all
  • K033666HemadermMedafor, Inc. · 2003 · cites it directly29descendants
  • K070211Traumarrest and Bleedarrest Hemostatic Particles and FoamHemostasis, LLC · 2007 · 2 generations on28descendants
  • K072900Excelarrest FoamHemostasis, LLC · 2007 · 3 generations on19descendants
  • K052099Nasopore Nasal Dressing, Model Ndox-Yyy/ZZPolyganics B.V., · 2005 · cites it directly17descendants
  • K080818Hemcon Bandage, Hemcon Bandage Otc, Hemcon Chitoflex-Surgical DressingHem Con Medical Technologies, Inc. · 2008 · 2 generations on11descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K972082Custom Nasal SplintBoston Medical Products, Inc.1997—
0 (this device)K012532Sepragel SinusGenzyme Corp.2001—
+1K033666HemadermMedafor, Inc.2003—
+2K070211Traumarrest and Bleedarrest Hemostatic Particles and FoamHemostasis, LLC2007—
+3K072900Excelarrest FoamHemostasis, LLC2007—
+1K052099Nasopore Nasal Dressing, Model Ndox-Yyy/ZZPolyganics B.V.,2005—
+2K080818Hemcon Bandage, Hemcon Bandage Otc, Hemcon Chitoflex-Surgical DressingHem Con Medical Technologies, Inc.2008—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
200520
200620
200750
200830
200920
201020
201110
201240
201320
201460
201520
201610
201720
201830
201940
202010
202110
202210
202310
202410
FIG. 1 — Lineage of K012532, 1997–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LYA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LYA device

  1. #1 K243655 TurbAlignscore 10.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K982731Merogel Nasal Dressing and Sinus Stent
Summary page 1
…nasal Splint Proprietary name: Hylasine™ 7.5 Legally Marketed Devices to Which Substantial Equivalence is Claimed Xomed MeroGel™ Nasal Dressing and Sinus Stent (Xomed, K982731) Custom Nasal Splint (Boston Medical, K972082) LactoSorb Ethmoid Stent (Walter Lorenz Surgical, K002131) Proprietary and Confide…
Xomed, Inc.1999—
*K972082Custom Nasal Splint
Summary page 1
…Legally Marketed Devices to Which Substantial Equivalence is Claimed Xomed MeroGel™ Nasal Dressing and Sinus Stent (Xomed, K982731) Custom Nasal Splint (Boston Medical, K972082) LactoSorb Ethmoid Stent (Walter Lorenz Surgical, K002131) Proprietary and Confidential Page 23 of 25 W Hylasine…
Boston Medical Products, Inc.1997—
*K002131Lactosorb Ethmoid Stent
Summary page 1
…is Claimed Xomed MeroGel™ Nasal Dressing and Sinus Stent (Xomed, K982731) Custom Nasal Splint (Boston Medical, K972082) LactoSorb Ethmoid Stent (Walter Lorenz Surgical, K002131) Proprietary and Confidential Page 23 of 25 W Hylasine™ Hylan B Gel Premarket [510(k)] Notification 7.6 Descri…
Walter Lorenz Surgical, Inc.2001—

Also cleared against K982731: 6 other devices →

What descends from it? (47)

See all 47

6 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K033666HemadermMedafor, Inc.200329
K052099Nasopore Nasal Dressing, Model Ndox-Yyy/ZZPolyganics B.V.,200517
K043035Sepragel Ent Bioresorbable Packing/StentGenzyme Corporation200510
K063308Advacoat Sinus Gel, Model 9100, Adva Sinus Stent, Model 9200Carbylan Biosurgery20064
K082276Synthemed DeviceSynthemed, Inc.20083
K070496Advacoat Sinus Gel and StentCarbylan Biosurgery20073

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 3 ancestors has a recall.
  • Of its descendants, K033666 (Medafor, Inc., 2003) has gone furthest, with 29 descendants of its own.
  • 6 other devices also cite its predicate K982731.

How does its category compare?

All LYA devices

LYA Splint, Intranasal Septal: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LYA

1in 2025

2007: 12008: 22009: 12012: 12013: 22014: 52016: 12017: 22018: 22020: 12021: 12023: 12025: 1
2007high 5 (2014) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LYA

104in 2014

2014: 104 days median
2007high 104 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LYA

No recall names LYA since 2007.

Adverse event reports per year · LYA

1in 2025

2007: 22009: 52010: 22011: 162012: 162013: 12014: 42015: 282016: 282017: 102018: 192019: 52020: 62021: 192022: 82023: 172024: 72025: 1
2007high 28 (2015) · low 0 (2008)2025

MAUDE reports naming product code LYA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—02
20082—00
20091—05
20100—02
20110—016
20121—016
20132—01
2014510404
20150—028
20161—028
20172—010
20182—019
20190—05
20201—06
20211—019
20220—08
20231—017
20240—07
20251—01
20260—0—

What is it indicated for?

HylaSine is indicated for use in patients undergoing nasal/sinus surgery as a space-occupying gel stent to separate and prevent adhesions between mucosal surfaces in the nasal cavity, to help control minimal bleeding following surgery or nasal trauma, and to prevent lateralization of the middle turbinate during the postoperative period.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K012532: Sepragel Sinus.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K012532

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026